--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "CURRENT Practice Guidelines" developer_entity: "Skyscape Medpresso Inc" bundle_id: "com.medpresso.Lonestar.pcguide" app_store_id: "1551780668" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-02-01" report_date: "2026-08-26" last_verified: "2026-08-26T00:00:00.000Z" report_version: "3.13.1" total_reviews: 65 overall_rating: 4.4 sentiment: "Mixed" sentiment_score: 55 confidence: "medium" confidence_score: 0.6 top_praise_theme: "The core utility of the application provides significant help to users during their daily tasks" top_complaint_theme: "Users express frustration because the application is not free of cost as they initially expected" review_sample_size: 6 total_review_count: 6 analyzed_review_count: 6 data_age_days: 75 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "mixed sentiment", "mobile app", "app review", "app analysis", "primary", "clinicians", "ambulatory"] canonical_url: "https://marlvel.ai/apps/current-practice-guidelines" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # CURRENT Practice Guidelines Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.43 · Sentiment Mixed - **Recent focus**: Users express frustration because the application is not free of cost as they initially expected (top complaint) · The core utility of the application provides significant help to users during their daily tasks (top praise) > **TL;DR:** CURRENT Practice Guidelines is a medical app by Skyscape Medpresso Inc, rated 4.43/5 by 65 users, with Mixed user sentiment (55/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** CURRENT Practice Guidelines shows Mixed sentiment (4.43/5 from 65 reviews) - users praise the core utility of the application provides significant help to users during their daily tasks but report issues with users express frustration because the application is not free of cost as they initially expected. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.43/5 (65 reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | Skyscape Medpresso Inc | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.6/1.0) | | **Data Age** | 75d | ## Metadata & Market Performance - **Publisher:** Skyscape Medpresso Inc - **Category:** Medical - **Target Audience:** Primary care clinicians and ambulatory medicine practitioners requiring quick access to evidence-based outpatient guidelines. - **Platforms:** iOS & Android - **Version Reviewed:** 5.8.5 - **Report Date:** 2026-08-26 - **Signal Count:** 6 reviews analyzed - **Confidence:** Medium (0.6/1.0) - **App Store ID (iOS):** 1551780668 - **Bundle ID:** com.medpresso.Lonestar.pcguide - **Google Play ID:** com.medpresso.Lonestar.pcguide - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-26 ## Executive Snapshot **What it is:** CURRENT Practice Guidelines is a clinical reference app for primary care practitioners, providing evidence-based outpatient recommendations in an outline-based format. **Why users hire it:** Clinicians use the tool to navigate conflicting medical guidelines and access distilled recommendations during patient consultations, removing the time cost of manual research. ## App DNA (Features & Intent) - **[Standard] Clinical Guideline Compendium:** Annual collection of evidence-based recommendations for outpatient conditions. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Differentiator] Guideline Discordance Tables:** Comparative data views highlighting where major medical guidelines differ. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Standard] Outline and Tabular Formatting:** Structured data presentation for rapid navigation during office practice. ## Market Position {#market-position} CURRENT Practice Guidelines competes in the medical reference space with a specialized, subscription-based clinical compendium. The $39.99 annual price point targets professional practitioners, though the lack of recent feature updates signals a focus on content maintenance over market share expansion. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free tier with sample content, Yearly auto-renewing subscription at $39.99 - **Analysis:** Subscription-only model anchored at $39.99/year, gating full clinical content behind an annual recurring payment. ## 🟡 User Sentiment (Medium Confidence: 6 of 6 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.43/5 - **Platform Split:** iOS 4.8/5 (24 ratings) | Android 4.2/5 (41 ratings) - **Overall Sentiment:** Mixed ### Top Praises - **The core utility of the application provides significant help to users during their daily tasks** ### Top Complaints (Impact Areas) - **Users express frustration because the application is not free of cost as they initially expected** ## SWOT Analysis {#swot} **Core Strengths:** - Guideline Discordance tables provide a differentiated view of conflicting medical recommendations - Outline-based formatting enables rapid navigation during office practice **Growth Levers:** - Implementing a transparent, tiered trial structure could reduce the refund surge driven by pricing confusion ## Recent Changes (v2 → v3) {#recent-changes} The application remains in a maintenance-only state with no functional updates, but the developer has pivoted its internal roadmap to prioritize pricing transparency and trial-based conversion strategies. **Overall trend**: Stable **Compared at**: 2026-08-26 ### High-impact changes - **[Shifted] Roadmap prioritization** (pricing) ### Medium-impact changes - **[Added] Trial structure opportunity** (swot) ## What's New - **Latest (v3.13.1, 6 months ago):** Optimized app performance and power efficiency through 16 KB page size support. ## App Momentum (Maintenance) {#momentum} - Ships maintenance-only updates. - Last major release February 2026. > **Cadence:** 2 total versions · 1 majors in last 6 months · 206 days since last update · 46 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} CURRENT Practice Guidelines is a medical app. With a 4.43/5 rating from 65 reviews, it shows mixed user reception. > **Bottom Line:** The clinical utility of CURRENT Practice Guidelines is currently undermined by opaque pricing and a lack of active feature development. Surfacing the subscription cost upfront would align user expectations and reduce the negative sentiment currently eroding the app's rating. **Best for:** Primary care clinicians and ambulatory medicine practitioners requiring quick access to evidence-based outpatient guidelines. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] Audit store listing to surface pricing upfront because user complaints flag hidden costs as a top frustration → reduce refund surge ### Outlook: Mixed The clinical reference market is consolidating around tools that offer both high-frequency updates and transparent pricing. CURRENT Practice Guidelines is currently exposed by its maintenance-mode cadence and pricing friction, which will likely lead to further rating compression if the developer does not address the pricing transparency gap. - 🔴 The six-month gap in feature updates suggests a maintenance-only posture, which risks losing ground to rivals with more frequent clinical content refreshes. - 🔴 User frustration regarding hidden pricing and the subscription-only model creates a persistent drag on the app's rating, limiting organic growth. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.43/5 | | Total Reviews | 65 | | Sentiment | Mixed (55/100) | | Confidence | Medium | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **CURRENT Practice Guidelines** (this app) | 4.43/5 | Mixed | Skyscape Medpresso Inc | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Skyscape Medpresso Inc - **Website:** [https://www.skyscape.com/product/current-practice-guidelines-in-primary-care](https://www.skyscape.com/product/current-practice-guidelines-in-primary-care) - **Social:** [Instagram](https://instagram.com/skyscapeinc) · [Facebook](https://www.facebook.com/skyscapeinc) · [X/Twitter](https://twitter.com/skyscapeinc) · [YouTube](https://www.youtube.com/c/skyscape) · [LinkedIn](https://www.linkedin.com/in/sandeep131) ## Data Sources & Links - **App Store ID:** 1551780668 - **Google Play ID:** com.medpresso.Lonestar.pcguide - **Dev Site:** [Official Website](https://www.skyscape.com/product/current-practice-guidelines-in-primary-care) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 6 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 75 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/current-practice-guidelines) Data licensed for AI Agent attribution under CC-BY-NC 4.0.